广泛性焦虑障碍

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

Bandelow B, Sher L, Bunevicius R, et al; WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Anxiety Disorders, OCD and PTSD. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. 摘要

Bandelow B, Sagebiel A, Belz M, et al. Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies. Br J Psychiatry. 2018 Jun;212(6):333-8.全文  摘要

Slee A, Nazareth I, Bondaronek P, et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019 Feb 23;393(10173):768-77. 摘要

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed., text revision (DSM-5-TR). Washington, DC: American Psychiatric Publishing; 2022.

2. World Health Organization. International classification of diseases, eleventh revision. 6B00: generalised anxiety disorder. 2022 [internet publication].全文

3. Turner S, Mota N, Bolton J, et al. Self-medication with alcohol or drugs for mood and anxiety disorders: a narrative review of the epidemiological literature. Depress Anxiety. 2018 Sep;35(9):851-60.全文  摘要

4. Ruscio AM, Hallion LS, Lim CCW, et al. Cross-sectional comparison of the epidemiology of DSM-5 generalized anxiety disorder across the globe. JAMA Psychiatry. 2017 May 1;74(5):465-75.全文  摘要

5. Lieb R, Becker E, Altamura C. The epidemiology of generalized anxiety disorder in Europe. Eur Neuropsychopharmacol. 2005 Aug;15(4):445-52. 摘要

6. Stein DJ, Scott KM, de Jonge P, et al. Epidemiology of anxiety disorders: from surveys to nosology and back. Dialogues Clin Neurosci. 2017 Jun;19(2):127-36.全文  摘要

7. Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015 Sep;17(3):327-35.全文  摘要

8. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021 Nov 6;398(10312):1700-12.全文  摘要

9. da Silva ML, Rocha RSB, Buheji M, et al. A systematic review of the prevalence of anxiety symptoms during coronavirus epidemics. J Health Psychol. 2021 Jan;26(1):115-25.全文  摘要

10. Remes O, Brayne C, van der Linde R, et al. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav. 2016 Jun 5;6(7):e00497.全文  摘要

11. Grenier S, Payette MC, Gunther B, et al. Association of age and gender with anxiety disorders in older adults: a systematic review and meta-analysis. Int J Geriatr Psychiatry. 2019 Mar;34(3):397-407. 摘要

12. Dennis CL, Falah-Hassani K, Shiri R. Prevalence of antenatal and postnatal anxiety: systematic review and meta-analysis. Br J Psychiatry. 2017 May;210(5):315-23.全文  摘要

13. Fawcett EJ, Fairbrother N, Cox ML, et al. The prevalence of anxiety disorders during pregnancy and the postpartum period: a multivariate Bayesian meta-analysis. J Clin Psychiatry. 2019 Jul 23;80(4):18r12527.全文  摘要

14. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994 Jan;51(1):8-19. 摘要

15. Alonso J, Angermeyer MC, Bemert S, et al. 12-month comorbidity and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 2004;420:28-37. 摘要

16. Kalin NH. The critical relationship between anxiety and depression. Am J Psychiatry. 2020 May 1;177(5):365-7.全文

17. Lamers F, van Oppen P, Comijs HC, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011 Mar;72(3):341-8. 摘要

18. Brantley PJ, Mehan DJ Jr, Ames SC, et al. Minor stressors and generalized anxiety disorders among low income patients attending primary care clinics. J Nerv Ment Dis. 1999 Jul;187(7):435-40. 摘要

19. Lau AW, Edelstein BA, Larkin KT. Psychophysiological arousal in older adults: a critical review. Clin Psychol Rev. 2001 Jun;21(4):609-30. 摘要

20. Brown ES, Fulton MK, Wilkeson A, et al. The psychiatric sequelae of civilian trauma. Compr Psychiatry. 2000 Jan-Feb;41(1):19-23. 摘要

21. National Institute for Health and Care Excellence. Generalised anxiety disorder and panic disorder in adults: management. Jun 2020 [internet publication].全文

22. Möller EL, Nikolić M, Majdandžić M, et al. Associations between maternal and paternal parenting behaviors, anxiety and its precursors in early childhood: a meta-analysis. Clin Psychol Rev. 2016 Apr;45:17-33. 摘要

23. Hawker DSJ, Boulton MJ. Twenty years' research on peer victimization and psychosocial maladjustment: a meta-analytic review of cross-sectional studies. J Child Psychol Psychiatry. 2000 May;41(4):441-55. 摘要

24. Hettema JM, Neale NC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001 Oct;158(10):1568-78.全文  摘要

25. Middeldorf CM, Cath CD, Van Dyck R, et al. The co-morbidity of anxiety and depression in the perspective of genetic epidemiology: a review of twin and family studies. Psychol Med. 2005 May;35(5):611-24. 摘要

26. Gottschalk MG, Domschke K. Genetics of generalized anxiety disorder and related traits. Dialogues Clin Neurosci. 2017 Jun;19(2):159-68.全文  摘要

27. Kalk NJ, Melichar J, Holmes RB, et al. Central noradrenergic responsiveness to a clonidine challenge in generalized anxiety disorder: a single photon emission computed tomography study. J Psychopharmacol. 2012 Apr;26(4):452-60. 摘要

28. Guo ZN, Lv S, Liu J, et al. Compromised dynamic cerebral autoregulation in patients with generalized anxiety disorder: a study using transfer function analysis. BMC Psychiatry. 2018 Jun 1;18(1):164.全文  摘要

29. Duits P, Cath DC, Lissek S, et al. Updated meta-analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety. 2015 Apr;32(4):239-53. 摘要

30. Milad MR, Rosenbaum BL, Simon NM. Neuroscience of fear extinction: implications for assessment and treatment of fear-based and anxiety related disorders. Behav Res Ther. 2014 Nov;62:17-23. 摘要

31. Schienle A, Hettema JM, Cáceda R, et al. Neurobiology and genetics of generalized anxiety disorder. Psychiatr Ann. 2011 Feb;41(2):113-23.全文

32. Saletu-Zyhlarz G, Saletu B, Anderer P, et al. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology. 1997;36(3):117-29. 摘要

33. Fonzo GA, Ramsawh HJ, Flagan TM, et al. Common and disorder-specific neural responses to emotional faces in generalised anxiety, social anxiety and panic disorders. Br J Psychiatry. 2015 Mar;206(3):206-15.全文  摘要

34. Stein MB, Simmons AN, Feinstein JS, et al. Increased amygdala and insula activation during emotion processing in anxiety-prone subjects. Am J Psychiatry. 2007 Feb;164(2):318-27.全文  摘要

35. Goossen B, van der Starre J, van der Heiden C. A review of neuroimaging studies in generalized anxiety disorder: "So where do we stand?" J Neural Transm (Vienna). 2019 Sep;126(9):1203-16. 摘要

36. Lawrence PJ, Murayama K, Creswell C. Systematic review and meta-analysis: anxiety and depressive disorders in offspring of parents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2019 Jan;58(1):46-60.全文  摘要

37. Vachon DD, Krueger RF, Rogosch FA, et al. Assessment of the harmful psychiatric and behavioral effects of different forms of child maltreatment. JAMA Psychiatry. 2015 Nov;72(11):1135-42.全文  摘要

38. Fricchione G. Generalized anxiety disorder. N Engl J Med. 2004 Aug 12;351(7):675-82.

39. Grigsby AM, Anderson RJ, Freedland KE, et al. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res. 2002 Dec;53(6):1053-60. 摘要

40. Rogers MP, White K, Warshaw MG, et al. Prevalence of medical illness in patients with anxiety disorders. Int J Psychiatry Med. 1994 Mar;24(1):83-96. 摘要

41. Schuch FB, Stubbs B, Meyer J, et al. Physical activity protects from incident anxiety: a meta-analysis of prospective cohort studies. Depress Anxiety. 2019 Sep;36(9):846-58. 摘要

42. Rapee RM, Kennedy SJ, Ingram M, et al. Altering the trajectory of anxiety in at-risk young children. Am J Psychiatry. 2010 Dec;167(12):1518-25.全文  摘要

43. Ginsburg GS. The Child Anxiety Prevention Study: intervention model and primary outcomes. J Consult Clin Psychol. 2009 Jun;77(3):580-7.全文  摘要

44. Alonso J, Liu Z, Evans-Lacko S, et al; WHO World Mental Health Survey Collaborators. Treatment gap for anxiety disorders is global: results of the World Mental Health Surveys in 21 countries. Depress Anxiety. 2018 Mar;35(3):195-208.全文  摘要

45. Olariu E, Forero CG, Castro-Rodriguez JI, et al. Detection of anxiety disorders in primary care: a meta-analysis of assisted and unassisted diagnoses. Depress Anxiety. 2015 Jul;32(7):471-84. 摘要

46. Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014 May;28(5):403-39. 摘要

47. Andrews G, Bell C, Boyce P, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised anxiety disorder. Aust N Z J Psychiatry. 2018 Nov;52(12):1109-72.全文

48. Katzman MA, Bleau P, Blier P, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. BMC Psychiatry. 2014 Jul;14 Suppl 1(suppl 1):S1.全文  摘要

49. Kessler RC, Ruscio AM, Shear K, et al. Epidemiology of anxiety disorders. Curr Top Behav Neurosci. 2010;2:21-35. 摘要

50. Penninx BW, Pine DS, Holmes EA, et al. Anxiety disorders. Lancet. 2021 Mar 6;397(10277):914-27.全文  摘要

51. Pary R, Matuschka PR, Lewis S. Generalized anxiety disorder. South Med J. 2003 Jun;96(6):581-6. 摘要

52. National Institute for Health and Care Excellence. Antenatal and postnatal mental health: clinical management and service guidance. Feb 2020 [internet publication].全文

53. American College of Obstetricians and Gynecologists. Screening and diagnosis of mental health conditions during pregnancy and postpartum. Jun 2023 [internet publication].全文

54. National Institute for Health and Care Excellence. Anxiety disorders. Feb 2014 [internet publication].全文

55. Goldstein-Piekarski AN, Williams LM, Humphreys K. A trans-diagnostic review of anxiety disorder comorbidity and the impact of multiple exclusion criteria on studying clinical outcomes in anxiety disorders. Transl Psychiatry. 2016 Jun 28;6(6):e847.全文  摘要

56. Klein B, Rajendram R, Hrycko S, et al; Canadian Paediatric Society. Anxiety in children and youth: part 1 - diagnosis. Paediatr Child Health. 2023 Feb;28(1):37-51.全文  摘要

57. Walter HJ, Bukstein OG, Abright AR, et al. Clinical practice guideline for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2020 Oct;59(10):1107-24.全文  摘要

58. Fischer S, Ehlert U. Hypothalamic-pituitary-thyroid (HPT) axis functioning in anxiety disorders. A systematic review. Depress Anxiety. 2018 Jan;35(1):98-110. 摘要

59. Stone J, Burton C, Carson A. Recognising and explaining functional neurological disorder. BMJ. 2020 Oct 21;371:m3745.

60. Brown RJ, Reuber M. Psychological and psychiatric aspects of psychogenic non-epileptic seizures (PNES): a systematic review. Clin Psychol Rev. 2016 Apr;45:157-82. 摘要

61. US Preventive Services Task Force. Final recommentation statement: anxiety disorders in adults: screening. Jun 2023 [internet publication].全文  摘要

62. US Preventive Services Task Force. Final recommentation statement: anxiety in children and adolescents: screening. Oct 2022.全文  摘要

63. Gregory KD, Chelmow D, Nelson HD, et al; Women’s Preventive Services Initiative. Screening for anxiety in adolescent and adult women: a recommendation from the women's preventive services initiative. Ann Intern Med. 2020 Jul 7;173(1):48-56.全文  摘要

64. Sinesi A, Maxwell M, O'Carroll R, et al. Anxiety scales used in pregnancy: systematic review. BJPsych Open. 2019 Jan;5(1):e5.全文  摘要

65. Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): a meta-analysis. CMAJ. 2012 Feb 21;184(3):E191-6.全文  摘要

66. Plummer F, Manea L, Trepel D, et al. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31. 摘要

67. Herr NR, Williams JW Jr, Benjamin S, et al. Does this patient have generalized anxiety or panic disorder?: the Rational Clinical Examination systematic review. JAMA. 2014 Jul 2;312(1):78-84. 摘要

68. Runyon K, Chesnut SR, Burley H. Screening for childhood anxiety: a meta-analysis of the screen for child anxiety related emotional disorders. J Affect Disord. 2018 Nov;240:220-9. 摘要

69. Piqueras JA, Martín-Vivar M, Sandin B, et al. The Revised Child Anxiety and Depression Scale: a systematic review and reliability generalization meta-analysis. J Affect Disord. 2017 Aug 15;218:153-69. 摘要

70. Bandelow B, Michaelis S, Wedekind D. Treatment of anxiety disorders. Dialogues Clin Neurosci. 2017 Jun;19(2):93-107.全文  摘要

71. Bandelow B, Sher L, Bunevicius R, et al; WFSBP Task Force on Mental Disorders in Primary Care; WFSBP Task Force on Anxiety Disorders, OCD and PTSD. Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012 Jun;16(2):77-84. 摘要

72. Bandelow B, Reitt M, Röver C, et al. Efficacy of treatments for anxiety disorders: a meta-analysis. Int Clin Psychopharmacol. 2015 Jul;30(4):183-92. 摘要

73. Schneider RL, Arch JJ, Wolitzky-Taylor KB. The state of personalized treatment for anxiety disorders: a systematic review of treatment moderators. Clin Psychol Rev. 2015 Jun;38:39-54. 摘要

74. Cuijpers P, Sijbrandij M, Koole SL, et al. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013 Jun;12(2):137-48.全文  摘要

75. Hofmann SG, Sawyer AT, Korte KJ, et al. Is it beneficial to add pharmacotherapy to cognitive-behavioral therapy when treating anxiety disorders? A meta-analytic review. Int J Cogn Ther. 2009 Jan 1;2(2):160-75.全文  摘要

76. Würz A, Sungur MZ. Combining cognitive behavioural therapy and pharmacotherapy in the treatment of anxiety disorders: true gains or false hopes? Bull Clin Psychopharmacol. 2009;19:436-46​.全文

77. de Vries YA, de Jonge P, van den Heuvel E, et al. Influence of baseline severity on antidepressant efficacy for anxiety disorders: meta-analysis and meta-regression. Br J Psychiatry. 2016 Jun;208(6):515-21.全文  摘要

78. Cuijpers P, Sijbrandij M, Koole S, et al. Psychological treatment of generalized anxiety disorder: a meta-analysis. Clin Psychol Rev. 2014 Mar;34(2):130-40. 摘要

79. Bandelow B, Sagebiel A, Belz M, et al. Enduring effects of psychological treatments for anxiety disorders: meta-analysis of follow-up studies. Br J Psychiatry. 2018 Jun;212(6):333-8.全文  摘要

80. Borkovec TD, Ruscio AM. Psychotherapy for generalized anxiety disorder. J Clin Psychiatry. 2001;62 Suppl 11:37-45. 摘要

81. Covin R, Ouimet AJ, Seeds PM, et al. A meta-analysis of CBT for pathological worry among clients with GAD. J Anxiety Disord. 2008;22(1):108-16. 摘要

82. Haby MM, Donnelly M, Corry J, et al. Cognitive behavioural therapy for depression, panic disorder and generalized anxiety disorder: a meta-regression of factors that may predict outcome. Aust N Z J Psychiatry. 2006 Jan;40(1):9-19. 摘要

83. Carpenter JK, Andrews LA, Witcraft SM, et al. Cognitive behavioral therapy for anxiety and related disorders: a meta-analysis of randomized placebo-controlled trials. Depress Anxiety. 2018 Jun;35(6):502-14.全文  摘要

84. Loerinc AG, Meuret AE, Twohig MP, et al. Response rates for CBT for anxiety disorders: need for standardized criteria. Clin Psychol Rev. 2015 Dec;42:72-82. 摘要

85. van Dis EAM, van Veen SC, Hagenaars MA, et al. Long-term outcomes of cognitive behavioral therapy for anxiety-related disorders: a systematic review and meta-analysis. JAMA Psychiatry. 2020 Mar 1;77(3):265-73.全文  摘要

86. Pinquart M, Duberstein PR. Treatment of anxiety disorders in older adults: a meta-analytic comparison of behavioral and pharmacological interventions. Am J Geriatr Psychiatry. 2007 Aug;15(8):639-51. 摘要

87. Thorp SR, Ayers CR, Nuevo R, et al. Meta-analysis comparing different behavioral treatments for late-life anxiety. Am J Geriatr Psychiatry. 2009 Feb;17(2):105-15.全文  摘要

88. Hendriks GJ, Oude Voshaar RC, Keijsers GP, et al. Cognitive-behavioural therapy for late-life anxiety disorders: a systematic review and meta-analysis. Acta Psychiatr Scand. 2008 Jun;117(6):403-11. 摘要

89. Hall J, Kellett S, Berrios R, et al. Efficacy of cognitive behavioral therapy for generalized anxiety disorder in older adults: systematic review, meta-analysis, and meta-regression. Am J Geriatr Psychiatry. 2016 Nov;24(11):1063-73. 摘要

90. Ye X, Bapuji SB, Winters SE, et al. Effectiveness of internet-based interventions for children, youth, and young adults with anxiety and/or depression: a systematic review and meta-analysis. BMC Health Serv Res. 2014 Jul 18;14:313.全文  摘要

91. Andrews G, Basu A, Cuijpers P, et al. Computer therapy for the anxiety and depression disorders is effective, acceptable and practical health care: an updated meta-analysis. J Anxiety Disord. 2018 Apr;55:70-8.全文  摘要

92. Coull G, Morris PG. The clinical effectiveness of CBT-based guided self-help interventions for anxiety and depressive disorders: a systematic review. Psychol Med. 2011 Nov;41(11):2239-52. 摘要

93. Newman MG, Szkodny LE, Llera SJ, et al. A review of technology-assisted self-help and minimal contact therapies for anxiety and depression: is human contact necessary for therapeutic efficacy? Clin Psychol Rev. 2011 Feb;31(1):89-103. 摘要

94. Saramago P, Gega L, Marshall D, et al. Digital interventions for generalized anxiety disorder (GAD): systematic review and network meta-analysis. Front Psychiatry. 2021 Dec 6;12:726222.全文  摘要

95. Lewis C, Pearce J, Bisson JI. Efficacy, cost-effectiveness and acceptability of self-help interventions for anxiety disorders: systematic review. Br J Psychiatry. 2012 Jan;200(1):15-21.全文  摘要

96. Firth J, Torous J, Nicholas J, et al. Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord. 2017 Aug 15;218:15-22.全文  摘要

97. Zalta AK. A meta-analysis of anxiety symptom prevention with cognitive-behavioral interventions. J Anxiety Disord. 2011 Jun;25(5):749-60. 摘要

98. Olthuis JV, Watt MC, Bailey K, et al. Therapist-supported internet cognitive behavioural therapy for anxiety disorders in adults. Cochrane Database Syst Rev. 2016 Mar 12;(3):CD011565.全文  摘要

99. Berryhill MB, Halli-Tierney A, Culmer N, et al. Videoconferencing psychological therapy and anxiety: a systematic review. Fam Pract. 2019 Jan 25;36(1):53-63.全文  摘要

100. Hoge EA, Bui E, Marques L, et al. Randomized controlled trial of mindfulness meditation for generalized anxiety disorder: effects on anxiety and stress reactivity. J Clin Psychiatry. 2013 Aug;74(8):786-92.全文  摘要

101. Wong SY, Yip BH, Mak WW, et al. Mindfulness-based cognitive therapy v. group psychoeducation for people with generalised anxiety disorder: randomised controlled trial. Br J Psychiatry. 2016 Jul;209(1):68-75.全文  摘要

102. Rodrigues MF, Nardi AE, Levitan M. Mindfulness in mood and anxiety disorders: a review of the literature. Trends Psychiatry Psychother. 2017 Jul-Sep;39(3):207-15.全文  摘要

103. Huang J, Nigatu YT, Smail-Crevier R, et al. Interventions for common mental health problems among university and college students: a systematic review and meta-analysis of randomized controlled trials. J Psychiatr Res. 2018 Dec;107:1-10. 摘要

104. Haller H, Breilmann P, Schröter M, et al. A systematic review and meta-analysis of acceptance- and mindfulness-based interventions for DSM-5 anxiety disorders. Sci Rep. 2021 Oct 14;11(1):20385.全文  摘要

105. Hoge EA, Bui E, Mete M, et al. Mindfulness-based stress reduction vs escitalopram for the treatment of adults with anxiety disorders: a randomized clinical trial. JAMA Psychiatry. 2023 Jan 1;80(1):13-21. 摘要

106. Montero-Marin J, Garcia-Campayo J, López-Montoyo A, et al. Is cognitive-behavioural therapy more effective than relaxation therapy in the treatment of anxiety disorders? A meta-analysis. Psychol Med. 2018 Jul;48(9):1427-36. 摘要

107. Kim HS, Kim EJ. Effects of relaxation therapy on anxiety disorders: a systematic review and meta-analysis. Arch Psychiatr Nurs. 2018 Apr;32(2):278-84. 摘要

108. Hunot V, Churchill R, Teixeira V, et al. Psychological therapies for generalised anxiety disorder. Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001848.全文  摘要

109. Leichsenring F, Salzer S, Jaeger U, et al. Short-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial. Am J Psychiatry. 2009 Aug;166(8):875-81.全文  摘要

110. Creswell C, Cruddace S, Gerry S, et al. Treatment of childhood anxiety disorder in the context of maternal anxiety disorder: a randomised controlled trial and economic analysis. Health Technol Assess. 2015 May;19(38):1-184.全文  摘要

111. Roszkowska J, Geraci SA. Management of insomnia in the geriatric patient. Am J Med. 2010 Dec;123(12):1087-90. 摘要

112. Roy-Byrne P, Veitengruber JP, Bystritsky A, et al. Brief intervention for anxiety in primary care patients. J Am Board Fam Med. 2009 Mar-Apr;22(2):175-86.全文  摘要

113. Kandola A, Vancampfort D, Herring M, et al. Moving to beat anxiety: epidemiology and therapeutic issues with physical activity for anxiety. Curr Psychiatry Rep. 2018 Jul 24;20(8):63.全文  摘要

114. Aylett E, Small N, Bower P. Exercise in the treatment of clinical anxiety in general practice - a systematic review and meta-analysis. BMC Health Serv Res. 2018 Jul 16;18(1):559.全文  摘要

115. Sabourin BC, Stewart SH, Watt MC, et al. Running as interoceptive exposure for decreasing anxiety sensitivity: replication and extension. Cogn Behav Ther. 2015;44(4):264-74. 摘要

116. Singh B, Olds T, Curtis R, et al. Effectiveness of physical activity interventions for improving depression, anxiety and distress: an overview of systematic reviews. Br J Sports Med. 2023 Feb 16 [Epub ahead of print].全文  摘要

117. Cramer H, Lauche R, Anheyer D, et al. Yoga for anxiety: a systematic review and meta-analysis of randomized controlled trials. Depress Anxiety. 2018 Sep;35(9):830-43.全文  摘要

118. van Boeijen CA, van Balkom AJ, van Oppen P, et al. Efficacy of self-help manuals for anxiety disorders in primary care: a systematic review. Fam Pract. 2005 Apr;22(2):192-6.全文  摘要

119. Haug T, Nordgreen T, Öst LG, et al. Self-help treatment of anxiety disorders: a meta-analysis and meta-regression of effects and potential moderators. Clin Psychol Rev. 2012 Jul;32(5):425-45. 摘要

120. Health Quality Ontario. Psychotherapy for major depressive disorder and generalized anxiety disorder: a health technology assessment. Ont Health Technol Assess Ser. 2017 Nov 13;17(15):1-167.全文  摘要

121. Zhang A, Park S, Sullivan JE, et al. The effectiveness of problem-solving therapy for primary care patients' depressive and/or anxiety disorders: a systematic review and meta-analysis. J Am Board Fam Med. 2018 Jan-Feb;31(1):139-50.全文  摘要

122. Kelson J, Rollin A, Ridout B, et al. Internet-delivered acceptance and commitment therapy for anxiety treatment: systematic review. J Med Internet Res. 2019 Jan 29;21(1):e12530.全文  摘要

123. Marker I, Norton PJ. The efficacy of incorporating motivational interviewing to cognitive behavior therapy for anxiety disorders: a review and meta-analysis. Clin Psychol Rev. 2018 Jun;62:1-10. 摘要

124. White KS, Payne LA, Gorman JM, et al. Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? A randomized controlled clinical trial. J Consult Clin Psychol. 2013 Feb;81(1):47-57.全文  摘要

125. Craske MG, Roy-Byrne P, Stein MB, et al. CBT intensity and outcome for panic disorder in a primary care setting. Behav Ther. 2006 Jun;37(2):112-9. 摘要

126. Wilson H, Mannix S, Oko-osi H, et al. The impact of medication on health-related quality of life in patients with generalized anxiety disorder. CNS Drugs. 2015 Jan;29(1):29-40. 摘要

127. Schmitt R, Gazalle FK, Lima MS, et al. The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis. Braz J Psychiatry. 2005 Mar;27(1):18-24.全文  摘要

128. Slee A, Nazareth I, Bondaronek P, et al. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis. Lancet. 2019 Feb 23;393(10173):768-77. 摘要

129. Gale C, Oakley-Browne M. Generalized anxiety disorder. Clin Evid. 2005 Dec;(14):1253-69.

130. Szuhany KL, Simon NM. Anxiety disorders: a review. JAMA. 2022 Dec 27;328(24):2431-45. 摘要

131. Sinclair LI, Christmas DM, Hood SD, et al. Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry. 2009 Jun;194(6):483-90. 摘要

132. Jakubovski E, Johnson JA, Nasir M, et al. Systematic review and meta-analysis: dose-response curve of SSRIs and SNRIs in anxiety disorders. Depress Anxiety. 2019 Mar;36(3):198-212. 摘要

133. Baldwin D, Woods R, Lawson R, et al. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis. BMJ. 2011 Mar 11;342:d1199.全文  摘要

134. Schuurmans J, Comijs H, Emmelkamp PM, et al. Long-term effectiveness and prediction of treatment outcome in cognitive behavioral therapy and sertraline for late-life anxiety disorders. Int Psychogeriatr. 2009 Dec;21(6):1148-59. 摘要

135. Ipser, JC, Stein DJ, Hawkridge S, et al. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005170.全文  摘要

136. Dobson ET, Strawn JR. Pharmacotherapy for pediatric generalized anxiety disorder: a systematic evaluation of efficacy, safety and tolerability. Paediatr Drugs. 2016 Feb;18(1):45-53.全文  摘要

137. Khan AY, Macaluso M. Duloxetine for the treatment of generalized anxiety disorder: a review. Neuropsychiatr Dis Treat. 2009;5:23-31.全文  摘要

138. Brawman-Mintzer O, Knapp RG, Rynn M, et al. Sertraline treatment for generalized anxiety disorder: a randomized, double-blind, placebo-controlled study. J Clinical Psychiatry. 2006 Jun;67(6):874-81. 摘要

139. Allgulander C, Florea I, Huusom AK. Prevention of relapse in generalized anxiety disorder by escitalopram treatment. Int J Neuropsychopharmacol. 2006 Oct;9(5):495-505. 摘要

140. Garakani A, Murrough JW, Freire RC, et al. Pharmacotherapy of anxiety disorders: current and emerging treatment options. Front Psychiatry. 2020 Dec 23;11:595584.全文  摘要

141. Allgulander C, Nutt D, Detke M, et al. A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder. J Psychopharmacol. 2008 Jun;22(4):417-25. 摘要

142. Allgulander C, Hartford J, Russell J, et al. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials. Curr Med Res Opin. 2007 Jun;23(6):1245-52. 摘要

143. Wu WY, Wang G, Ball SG, et al. Duloxetine versus placebo in the treatment of patients with generalized anxiety disorder in China. Chin Med J (Engl). 2011 Oct;124(20):3260-8. 摘要

144. Chessick CA, Allen MH, Thase M, et al. Azapirones for generalized anxiety disorder. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006115.全文  摘要

145. Boschen MJ. A meta-analysis of the efficacy of pregabalin in the treatment of generalized anxiety disorder. Can J Psychiatry. 2011 Sep;56(9):558-66. 摘要

146. Wensel TM, Powe KW, Cates ME. Pregabalin for the treatment of generalized anxiety disorder. Ann Pharmacother. 2012 Mar;46(3):424-9. 摘要

147. Rickels K, Shiovitz TM, Ramey TS, et al. Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment. Int Clin Psychopharmacol. 2012 May;27(3):142-50. 摘要

148. Generoso MB, Trevizol AP, Kasper S, et al. Pregabalin for generalized anxiety disorder: an updated systematic review and meta-analysis. Int Clin Psychopharmacol. 2017 Jan;32(1):49-55. 摘要

149. Buoli M, Caldiroli A, Serati M. Pharmacokinetic evaluation of pregabalin for the treatment of generalized anxiety disorder. Expert Opin Drug Metab Toxicol. 2017 Mar;13(3):351-9. 摘要

150. Bonnet U, Scherbaum N. How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol. 2017 Dec;27(12):1185-215. 摘要

151. Public Health England, NHS England. Pregabalin and gabapentin: advice for prescribers on the risk of misuse. Dec 2014 [internet publication].全文

152. Shammas E. Controlled comparison of bromazepam, amitriptyline, and placebo in anxiety-depressive neurosis. Dis Nerv Syst. 1977 Mar;38(3):201-7. 摘要

153. Goldberg HL, Finnery RJ. The use of doxepin in the treatment of symptoms of anxiety neurosis and accompanying depression: a collaborative controlled study. Am J Psychiatry. 1972 Jul;129(1):74-7.

154. Craske MG, Stein MB. Anxiety. Lancet. 2016 Dec 17;388(10063):3048-59. 摘要

155. LaLonde CD, Van Lieshout RJ. Treating generalized anxiety disorder with second generation antipsychotics: a systematic review and meta-analysis. J Clin Psychopharmacol. 2011 Jun;31(3):326-33. 摘要

156. Maneeton N, Maneeton B, Woottiluk P, et al. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther. 2016 Jan 12;10:259-76.全文  摘要

157. Donnelly K, Bracchi R, Hewitt J, et al. Benzodiazepines, Z-drugs and the risk of hip fracture: a systematic review and meta-analysis. PLoS One. 2017 Apr 27;12(4):e0174730.全文  摘要

158. Née M, Avalos M, Luxcey A, et al. Prescription medicine use by pedestrians and the risk of injurious road traffic crashes: a case-crossover study. PLoS Med. 2017 Jul 18;14(7):e1002347.全文  摘要

159. Gomez AF, Barthel AL, Hofmann SG. Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review. Expert Opin Pharmacother. 2018 Jun;19(8):883-94.全文  摘要

160. Silberman E, Balon R, Starcevic V, et al. Benzodiazepines: it's time to return to the evidence. Br J Psychiatry. 2021 Mar;218(3):125-7.全文  摘要

161. Balon R, Chouinard G, Cosci F, et al. International task force on benzodiazepines. Psychother Psychosom. 2018;87(4):193-4.全文

162. Krystal JH, Stossel S, Krystal AD. Restricting benzodiazepines to short-term prescription. JAMA Psychiatry. 2015 Jul;72(7):734-5.

163. Shinfuku M, Kishimoto T, Uchida H, et al. Effectiveness and safety of long-term benzodiazepine use in anxiety disorders: a systematic review and meta-analysis. Int Clin Psychopharmacol. 2019 Sep;34(5):211-21. 摘要

164. Gale C, Glue P, Guaiana G, et al. Influence of covariates on heterogeneity in Hamilton Anxiety Scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorder: systematic review and meta-analysis. J Psychopharmacol. 2019 May;33(5):543-7. 摘要

165. Petrushevska T, Jakovski Z, Poposka V, et al. Drug-related deaths between 2002 and 2013 with accent to methadone and benzodiazepines. J Forensic Leg Med. 2015 Apr;31:12-8. 摘要

166. Lintzeris N, Nielsen S. Benzodiazepines, methadone and buprenorphine: interactions and clinical management. Am J Addict. 2010 Jan-Feb;19(1):59-72. 摘要

167. Jones CM, McAninch JK. Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. Am J Prev Med. 2015 Oct;49(4):493-501. 摘要

168. Kennedy KM, O'Riordan J. Prescribing benzodiazepines in general practice. Br J Gen Pract. 2019 Mar;69(680):152-3.全文

169. Batelaan NM, Bosman RC, Muntingh A, et al. Risk of relapse after antidepressant discontinuation in anxiety disorders, obsessive-compulsive disorder, and post-traumatic stress disorder: systematic review and meta-analysis of relapse prevention trials. BMJ. 2017 Sep 13;358:j3927.全文  摘要

170. Van Leeuwen E, van Driel ML, Horowitz MA, et al. Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults. Cochrane Database Syst Rev. 2021 Apr 15;(4):CD013495.全文  摘要

171. Mancini M, Perna G, Rossi A, et al. Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature. Expert Opin Pharmacother. 2010 May;11(7):1167-81. 摘要

172. Youssef NA, Rich CL. Does acute treatment with sedatives/hypnotics for anxiety in depressed patients affect suicide risk? A literature review. Ann Clin Psychiatry. 2008 Jul-Sep;20(3):157-69. 摘要

173. Bobbitt S, Kawamura A, Saunders N, et al; Canadian Paediatric Society. Anxiety in children and youth: part 2 - the management of anxiety disorders. Paediatr Child Health. 2023 Feb;28(1):52-66.全文  摘要

174. Crowe K, McKay D. Efficacy of cognitive-behavioral therapy for childhood anxiety and depression. J Anxiety Disord. 2017 Jun;49:76-87. 摘要

175. Guidelines and Protocols Advisory Committee; British Columbia Medical Association. Anxiety and depression in children and youth - diagnosis and treatment. Mar 2010 [internet publication].全文

176. Wang Z, Whiteside SPH, Sim L, et al. Comparative effectiveness and safety of cognitive behavioral therapy and pharmacotherapy for childhood anxiety disorders: a systematic review and meta-analysis. JAMA Pediatr. 2017 Nov 1;171(11):1049-56.全文  摘要

177. James AC, Reardon T, Soler A, et al. Cognitive behavioural therapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev. 2020 Nov 16;(11):CD013162.全文  摘要

178. Mahdi M, Jhawar S, Bennett SD, et al. Cognitive behavioral therapy for childhood anxiety disorders: what happens to comorbid mood and behavioral disorders? A systematic review. J Affect Disord. 2019 May 15;251:141-8. 摘要

179. Griffiths KM. SPARX computerised CBT is as effective as usual care for mild-to-moderate depression in help seeking adolescents. Evid Based Ment Health. 2012 Nov;15(4):90.

180. National Institute for Health and Care Excellence. ​Guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of anxiety or low mood: early value assessment. Feb 2023 [internet publication].全文

181. Monga S, Rosenbloom BN, Tanha A, et al. Comparison of child-parent and parent-only cognitive-behavioral therapy programs for anxious children aged 5 to 7 years: short- and long-term outcomes. J Am Acad Child Adolesc Psychiatry. 2015 Feb;54(2):138-46. 摘要

182. Donoghue K, Stallard P, Kucia J. The clinical practice of cognitive behavioural therapy for children and young people with a diagnosis of Asperger's syndrome. Clin Child Psychol Psychiatry. 2011 Jan;16(1):89-102. 摘要

183. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008 Dec 25;359(26):2753-66.全文  摘要

184. Dobson ET, Bloch MH, Strawn JR. Efficacy and tolerability of pharmacotherapy for pediatric anxiety disorders: a network meta-analysis. J Clin Psychiatry. 2019 Jan 29;80(1):17r12064.

185. Locher C, Koechlin H, Zion SR, et al. Efficacy and safety of selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and placebo for common psychiatric disorders among children and adolescents: a systematic review and meta-analysis. JAMA Psychiatry. 2017 Oct 1;74(10):1011-20.全文  摘要

186. Strawn JR, Mills JA, Sauley BA, et al. The impact of antidepressant dose and class on treatment response in pediatric anxiety disorders: a meta-analysis. J Am Acad Child Adolesc Psychiatry. 2018 Apr;57(4):235-44.全文  摘要

187. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA. 2007 Apr 18;297(15):1683-96. 摘要

188. Gale CK, Millichamp J. Generalised anxiety disorder in children and adolescents. BMJ Clin Evid. 2016 Jan 13;2016.全文  摘要

189. Hathaway EE, Walkup JT, Strawn JR. Antidepressant treatment duration in pediatric depressive and anxiety disorders: how long is long enough? Curr Probl Pediatr Adolesc Health Care. 2018 Feb;48(2):31-9.全文  摘要

190. American College of Obstetricians and Gynecologists. Treatment and management of mental health conditions during pregnancy and postpartum. Jun 2023 [internet publication].全文

191. Maguire PN, Clark GI, Wootton BM. The efficacy of cognitive behavior therapy for the treatment of perinatal anxiety symptoms: a preliminary meta-analysis. J Anxiety Disord. 2018 Dec;60:26-34. 摘要

192. Bayrampour H, Trieu J, Tharmaratnam T. Effectiveness of eHealth interventions to reduce perinatal anxiety: a systematic review and meta-analysis. J Clin Psychiatry. 2019 Jan 22;80(1):18r12386. 摘要

193. McAllister-Williams RH, Baldwin DS, Cantwell R, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol. 2017 May;31(5):519-52. 摘要

194. Massachusetts General Hospital Center for Women’s Mental Health. Psychiatric disorders during pregnancy. 2013 [internet publication].全文

195. Yonkers KA, Gilstad-Hayden K, Forray A, et al. Association of panic disorder, generalized anxiety disorder, and benzodiazepine treatment during pregnancy with risk of adverse birth outcomes. JAMA Psychiatry. 2017 Nov 1;74(11):1145-52.全文  摘要

196. Medicines and Healthcare products Regulatory Agency. SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery. Jan 2021 [internet publication].全文

197. Rai D, Lee B, Dalman C, et al. Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ. 2017 Jul 19;358:j2811.全文  摘要

198. Kaplan YC, Keskin-Arslan E, Acar S, et al. Maternal SSRI discontinuation, use, psychiatric disorder and the risk of autism in children: a meta-analysis of cohort studies. Br J Clin Pharmacol. 2017 Dec;83(12):2798-806.全文  摘要

199. Brown HK, Hussain-Shamsy N, Lunsky Y, et al. The association between antenatal exposure to selective serotonin reuptake inhibitors and autism: a systematic review and meta-analysis. J Clin Psychiatry. 2017 Jan;78(1):e48-58. 摘要

200. Andrade C. Safety of pregabalin in pregnancy. J Clin Psychiatry. 2018 Oct 2;79(5):18f12568.全文  摘要

201. Ray S, Stowe ZN. The use of antidepressant medication in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2014 Jan;28(1):71-83. 摘要

202. Andrews G, Hobbs MJ. The effect of the draft DSM-5 criteria for GAD on prevalence and severity. Aust N Z J Psychiatry. 2010 Sep;44(9):784-90. 摘要

203. Knekt P, Lindfors O, Laaksonen MA, et al; Helsinki Psychotherapy Study Group. Quasi-experimental study on the effectiveness of psychoanalysis, long-term and short-term psychotherapy on psychiatric symptoms, work ability and functional capacity during a 5-year follow-up. J Affect Disord. 2011 Jul;132(1-2):37-47. 摘要

204. Cirillo P, Gold AK, Nardi AE, et al. Transcranial magnetic stimulation in anxiety and trauma-related disorders: a systematic review and meta-analysis. Brain Behav. 2019 Jun;9(6):e01284.全文  摘要

205. Cox J, Thakur B, Alvarado L, et al. Repetitive transcranial magnetic stimulation for generalized anxiety and panic disorders: a systematic review and meta-analysis. Ann Clin Psychiatry. 2022 Aug;34(3):152-6, e10-7. 摘要

206. Glue P, Neehoff S, Sabadel A, et al. Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: exploratory double-blind psychoactive-controlled replication study. J Psychopharmacol. 2020 Mar;34(3):267-72. 摘要

207. Tully JL, Dahlén AD, Haggarty CJ, et al. Ketamine treatment for refractory anxiety: a systematic review. Br J Clin Pharmacol. 2022 Oct;88(10):4412-26.全文  摘要

208. Short B, Fong J, Galvez V, et al. Side-effects associated with ketamine use in depression: a systematic review. Lancet Psychiatry. 2018 Jan;5(1):65-78. 摘要

209. Stein DJ, Ahokas A, Jarema M, et al. Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: a 12-week, double-blind, placebo-controlled study. Eur Neuropsychopharmacol. 2017 May;27(5):526-37.全文  摘要

210. Stein DJ, Ahokas A, Márquez MS, et al. Agomelatine in generalized anxiety disorder: an active comparator and placebo-controlled study. J Clin Psychiatry. 2014 Apr;75(4):362-8. 摘要

211. Springer KS, Levy HC, Tolin DF. Remission in CBT for adult anxiety disorders: a meta-analysis. Clin Psychol Rev. 2018 Apr;61:1-8. 摘要

212. Kessler RC, DuPont RL, Berglund P, et al. Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys. Am J Psychiatry. 1999 Dec;156(12):1915-23.全文  摘要

213. Hall WD, Mant A, Mitchell PB, et al. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ. 2003 May 10;326(7397):1008.全文  摘要

214. Whooley MA, Simon GE. Managing depression in medical outpatients. N Engl J Med. 2000 Dec 28;343(26):1942-50.

215. Glasheen C, Richardson GA, Fabio A. A systematic review of the effects of postnatal maternal anxiety on children. Arch Womens Ment Health. 2010 Feb;13(1):61-74.全文  摘要

216. Field T. Prenatal anxiety effects: a review. Infant Behav Dev. 2017 Nov;49:120-8. 摘要

217. Adamson B, Letourneau N, Lebel C. Prenatal maternal anxiety and children's brain structure and function: a systematic review of neuroimaging studies. J Affect Disord. 2018 Dec 1;241:117-26. 摘要

218. Cohen JM, Wood ME, Hernández-Díaz S, et al. Paternal antidepressant use as a negative control for maternal use: assessing familial confounding on gestational length and anxiety traits in offspring. Int J Epidemiol. 2019 Oct 1;48(5):1665-72.全文  摘要

219. Davidson JR, Wittchen HU, Llorca PM, et al. Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial. Eur Neuropsychopharmacol. 2008 Sep;18(9):673-81. 摘要

220. Feltner D, Wittchen HU, Kavoussi R, et al. Long-term efficacy of pregabalin in generalized anxiety disorder. Int Clin Psychopharmacol. 2008 Jan;23(1):18-28. 摘要